Intravascular large B-cell lymphoma: an elusive diagnosis with challenging managementDecember 6, 2018Lymphoma & Plasma Cell Disorders
Symptom burdens related to chemotherapy-induced anemia in stage IV cancerDecember 5, 2018Patient & Survivor CareBreast CancerLung CancerLymphoma & Plasma Cell Disorders
2018: A banner year for hematology drug approvalsDecember 5, 2018Business of MedicineMixed TopicsLymphoma & Plasma Cell DisordersRare Diseases
CLL resistance mechanism to venetoclax identifiedDecember 5, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
In IDH-mutated AML, first-line IDH inhibitors plus chemo may boost remissionDecember 5, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
Patterns of malignancies in patients with HIV-AIDS: a single institution observational studyNovember 27, 2018Patient & Survivor CareSarcoma & GISTGynecologic CancerLymphoma & Plasma Cell Disorders
Malignant olecranon bursitis in the setting of multiple myeloma relapseNovember 26, 2018Lymphoma & Plasma Cell DisordersPatient & Survivor Care
Immunotherapy may hold the key to defeating virally associated cancersNovember 25, 2018Head & Neck/Thyroid CancersGenitourinary CancerGynecologic CancerGastroenterologyImmunotherapyLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
A ‘double-hit’ bone marrow rare co-occurrence of 2 different pathologiesNovember 13, 2018Lymphoma & Plasma Cell Disorders
Venetoclax approved to treat CLL patients regardless of genotypeOctober 28, 2018Lymphoma & Plasma Cell Disorders
Dr David Henry's top ASCO selections in hematology and bone healthAugust 15, 2018Lymphoma & Plasma Cell Disorders
New myeloma drugs improve response and extend survivalAugust 15, 2018Lymphoma & Plasma Cell Disorders
First CAR T-cell therapy approvals bolster booming immunotherapy marketAugust 15, 2018Lymphoma & Plasma Cell DisordersLeukemia, Myelodysplasia, Transplantation
An unusual case of primary cardiac prosthetic valve-associated lymphomaAugust 15, 2018Lymphoma & Plasma Cell DisordersPatient & Survivor Care
Meeting the potential of immunotherapy: new targets provide rational combinationsAugust 15, 2018GastroenterologyBreast CancerGenitourinary CancerHead & Neck/Thyroid CancersImmunotherapyLymphoma & Plasma Cell DisordersMelanoma
